
Antiviral drug was firstly reported regarding thiosemicarbazones developed for poxviruses in 1951. Then, human beings have been developed antiviral drugs using the latest technolo- gies including drug-design by computer, selection from huge compounds, antibodies and ge- nome editing. However, drug-resistant viruses always emerge because viruses are able to easily mutate. Although Favipiravir, which is a broad-spectrum antiviral drug, became a hot topic by having antiviral activity to several viruses including ebolavirus, viral drug-resistance would have been appeared by mutation in chikungunya virus. In this paper, the herpesvirus, HIV and influenza virus were focused to introduce development of antiviral drugs and the mechanism for emergence of drug-resistance.
Drug Resistance, Viral, Humans, Antiviral Agents
Drug Resistance, Viral, Humans, Antiviral Agents
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
